TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad Revenue

TMC Life Sciences Berhad had revenue of 89.70M MYR in the quarter ending March 31, 2026, a decrease of -0.19%. This brings the company's revenue in the last twelve months to 387.04M, up 18.58% year-over-year. In the fiscal year ending June 30, 2025, TMC Life Sciences Berhad had annual revenue of 345.63M, down -0.23%.

• Revenue (ttm): 387.04M
• Revenue Growth: +18.58%
• P/S Ratio: 1.98
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 766.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	345.63M	-784.00K	-0.23%
Jun 30, 2024	346.42M	34.86M	11.19%
Jun 30, 2023	311.56M	67.78M	27.81%
Jun 30, 2022	243.77M	42.75M	21.27%
Jun 30, 2021	201.02M	16.94M	9.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error